Amanote Research
Register
Sign In
Pdb61 - Cost-Effectiveness Analysis of Human or Analogue Basal Insulin-Supported Oral Therapy in Type 2 Diabetes in Hungary
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.766
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
T. Németh
Á Tabák
A. Bán
M. Bacskai
M. Tarcsa
Publisher
Elsevier BV
Related search
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Clinical Benefit of Basal Insulin Analogue Treatment in Persons With Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effectiveness of Insulin Therapy in People With Type 2 Diabetes in the Hoorn Diabetes Care System
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes on Oral Antidiabetic Drugs in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Retrospective Database Analysis of Insulin Use Patterns in Insulin-Naïve Patients With Type 2 Diabetes Initiating Basal Insulin or Mixtures
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or Prandial Insulin? The APOLLO Trial and Beyond
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Glycemic Control After Initiating Basal Insulin Therapy in Patients With Type 2 Diabetes: A Primary Care Database Analysis
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
